KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to $242.2 million.

  • Pacific Biosciences Of California's Short-term Investments fell 3840.07% to $242.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $242.2 million, marking a year-over-year decrease of 3840.07%. This contributed to the annual value of $334.6 million for FY2024, which is 2590.09% down from last year.
  • Latest data reveals that Pacific Biosciences Of California reported Short-term Investments of $242.2 million as of Q3 2025, which was down 3840.07% from $259.9 million recorded in Q2 2025.
  • In the past 5 years, Pacific Biosciences Of California's Short-term Investments ranged from a high of $684.6 million in Q2 2021 and a low of $227.9 million during Q1 2021
  • Its 5-year average for Short-term Investments is $454.5 million, with a median of $451.5 million in 2023.
  • Per our database at Business Quant, Pacific Biosciences Of California's Short-term Investments skyrocketed by 79346.13% in 2021 and then plummeted by 4135.14% in 2025.
  • Pacific Biosciences Of California's Short-term Investments (Quarter) stood at $583.7 million in 2021, then fell by 23.38% to $447.2 million in 2022, then increased by 0.96% to $451.5 million in 2023, then decreased by 25.9% to $334.6 million in 2024, then decreased by 27.61% to $242.2 million in 2025.
  • Its Short-term Investments was $242.2 million in Q3 2025, compared to $259.9 million in Q2 2025 and $284.6 million in Q1 2025.